Mori Hideo, Yoshida Hiroko, Mori Hideharu, Shiraki Tomoya, Kawakami Koichi
Pathology, Osaka Habikino Medical Center, Osaka, JPN.
Clinical Diagnosis, Osaka Habikino Medical Center, Osaka, JPN.
Cureus. 2023 Mar 19;15(3):e36373. doi: 10.7759/cureus.36373. eCollection 2023 Mar.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that is causing a worldwide pandemic since the spring of 2020. In Osaka, the second biggest prefecture in Japan, we identified a novel SARS-CoV-2 variant from a coronavirus disease 2019 (COVID-19) patient that was detected by polymerase chain reaction (PCR) using E primers, but not by real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR) using the N1 and N2 primer-probe sets recommended by CDC. We analyzed the S and N gene regions by reverse-transcription and nested PCR using the S and N specific primers, and DNA sequencing, and found that this BA.5 variant contained point mutations in the probe sequences of both the N1 and N2 primer-probe regions. This finding led us to affirm the importance of monitoring the genome sequence of the SARS-CoV-2 variants continuously.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是一种新型冠状病毒,自2020年春季以来在全球范围内引发大流行。在日本第二大县大阪,我们从一名2019冠状病毒病(COVID-19)患者身上鉴定出一种新型SARS-CoV-2变体,该患者通过使用E引物的聚合酶链反应(PCR)检测到,但未通过美国疾病控制与预防中心(CDC)推荐的使用N1和N2引物-探针组的实时定量逆转录聚合酶链反应(RT-qPCR)检测到。我们使用S和N特异性引物通过逆转录和巢式PCR以及DNA测序分析了S和N基因区域,发现该BA.5变体在N1和N2引物-探针区域的探针序列中均含有点突变。这一发现使我们认识到持续监测SARS-CoV-2变体基因组序列的重要性。